LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

LLY

1,040.03

+0.29%↑

JNJ

243.3

-0.53%↓

ABBV

231.41

+1.75%↑

NVS

162.81

+1.21%↑

MRK

121.33

+1.83%↑

Search

Neogen Corp

Fermé

SecteurSoins de santé

10.92 1.49

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.86

Max

10.95

Chiffres clés

By Trading Economics

Revenu

-52M

-16M

Ventes

16M

225M

Marge bénéficiaire

-7.087

Employés

2,974

EBITDA

-66M

23M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

-2.47% downside

Dividendes

By Dow Jones

Prochains Résultats

8 avr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

730M

2.3B

Ouverture précédente

9.43

Clôture précédente

10.92

Sentiment de l'Actualité

By Acuity

41%

59%

94 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bullish Evidence

Neogen Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

15 févr. 2026, 23:21 UTC

Acquisitions, Fusions, Rachats

Qube Agrees to Takeover by MAM-Led Consortium Valuing Its Equity at $6.51 Billion

15 févr. 2026, 23:45 UTC

Market Talk

Nikkei May Rise as Fears About AI Disruption Recede -- Market Talk

15 févr. 2026, 23:40 UTC

Market Talk

Gold Falls on Possible Position Adjustments -- Market Talk

15 févr. 2026, 23:06 UTC

Résultats

Thai Beverage: Spirits, Beer Businesses Posted Satisfactory EBITDA Growth, Alongside Profit Margin Expansion>Y92.SG

15 févr. 2026, 23:04 UTC

Résultats

Thai Beverage 1Q Beer Business EBITDA THB4.64B, Up 4.7% on Year>Y92.SG

15 févr. 2026, 23:04 UTC

Résultats

Thai Beverage 1Q Spirits Business EBITDA THB8.50B, Up 6.9% on Year >Y92.SG

15 févr. 2026, 23:01 UTC

Résultats

Thai Beverage 1Q EBITDA THB16.75B, Up 1.8% on Year >Y92.SG

15 févr. 2026, 23:01 UTC

Résultats

Thai Beverage 1Q FY Sales Revenue THB86.70B, Down 6.0% on Year>Y92.SG

15 févr. 2026, 22:53 UTC

Acquisitions, Fusions, Rachats

Qube: MAM-Led Offer Implies A$11.7 Billion Enterprise Value

15 févr. 2026, 22:53 UTC

Acquisitions, Fusions, Rachats

Qube: UniSuper to Transfer 15.07% Stake to Equivalent Ownership of Consortium Holding Structure

15 févr. 2026, 22:52 UTC

Acquisitions, Fusions, Rachats

Qube Shareholders to Receive A$5.20/Share in Cash

15 févr. 2026, 22:52 UTC

Acquisitions, Fusions, Rachats

Qube Holdings Agrees to Takeover by Macquarie Asset Management-Led Consortium

15 févr. 2026, 22:22 UTC

Acquisitions, Fusions, Rachats

BlueScope CEO Tania Archibald Speaking on a Call With Media

15 févr. 2026, 22:17 UTC

Acquisitions, Fusions, Rachats

BlueScope CEO: Stresses Whyalla Project Would Have to Make Sense to Shareholders

15 févr. 2026, 22:16 UTC

Acquisitions, Fusions, Rachats

BlueScope CEO: Some Job Cuts Inevitable to Ensure Company is Competitive

15 févr. 2026, 22:14 UTC

Acquisitions, Fusions, Rachats

BlueScope CEO: Higher Returns Tied to End of Capital Investment Program

15 févr. 2026, 22:14 UTC

Acquisitions, Fusions, Rachats

BlueScope Steel CEO: Higher Returns After Rebuffed Takeover Bid a 'Natural Coincidence'

15 févr. 2026, 20:48 UTC

Résultats

BlueScope: Will Now Target Net Debt of Up to A$1.5 Billion; Will Surpass as Needed

15 févr. 2026, 20:47 UTC

Résultats

BlueScope: Expects Full Benefits of Further A$150M Cost Savings in FY 2027

15 févr. 2026, 20:46 UTC

Résultats

BlueScope: Recorded Net Annualized Cost Improvements of A$190 Million in 1H

15 févr. 2026, 20:45 UTC

Résultats

BlueScope Expects a One-Third Lower 2H Result From Asia Business Vs 1H

15 févr. 2026, 20:44 UTC

Résultats

BlueScope Expects 15% Higher 2H Result From North America Business Vs 1H

15 févr. 2026, 20:44 UTC

Résultats

BlueScope Expects Lower 2H Result From Australia Business Vs 1H

15 févr. 2026, 20:43 UTC

Résultats

BlueScope Expects 2H Underlying Ebit of A$620 Million-A$700 Million

15 févr. 2026, 20:42 UTC

Résultats

BlueScope Net Debt A$2.2 Million at Dec. 31

15 févr. 2026, 20:42 UTC

Résultats

BlueScope 1H Underlying Ebit A$557.5 Million, Up 81% On-Year

15 févr. 2026, 20:41 UTC

Résultats

BlueScope 1H Underlying Ebitda A$915.3 Million, Up 39% On-Year

15 févr. 2026, 20:40 UTC

Résultats

BlueScope 1H Underlying Profit A$382.0 Million Vs A$176.4 Million Year Prior

15 févr. 2026, 20:40 UTC

Résultats

BlueScope 1H Sales Revenue From Continuing Ops A$8.22 Billion, Up 4% On-Year

15 févr. 2026, 20:39 UTC

Résultats

BlueScope Intends to Spend A$310 Million on Buyback, Or Other Returns if Share Repurchases Limited

Comparaison

Variation de prix

Neogen Corp prévision

Objectif de Prix

By TipRanks

-2.47% baisse

Prévisions sur 12 Mois

Moyen 10.67 USD  -2.47%

Haut 12 USD

Bas 10 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

4 ratings

2

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

5.17 / 5.99Support & Résistance

Court Terme

Strong Bullish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

94 / 351Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
help-icon Live chat